Prevention and Intervention
Prevention and intervention activities are paramount to reducing the number of overdose deaths in the United States. Evidence-based programs that promote appropriate screening and interventions and educate healthcare professionals about the potential dangers of prescribing controlled substances, programs that educate children about the risks of underage drinking and programs that improve the culture around prescription drug misuse and abuse, illicit drug use, tobacco use and alcoholism are essential to preventing the unending suffering from substance use disorder.
Search for NAMSDL materials about drug and alcohol abuse prevention and intervention
Document Selector
Type of Document
Subject
Source of Document
Results
July 2019
A model law that requires use of the most effective practices to transfer stabilized overdose survivors directly and immediately to clinically appropriate treatment and recovery support services.
January 2019
The 2019 National Drug Control Strategy from the Office of National Drug Control Policy (ONDCP) that establishes the national initiatives and priorities to combat illicit drug use and treat people suffering from substance use disorders.
September 2018
A model law that requires use of the most effective practices to transfer stabilized overdose survivors directly and immediately to clinically appropriate treatment and recovery support services.
May 2016
Controlled Substances Return and Disposal: 2016 Legislative Session Bill Status Update
February 2016
50 state compilation of states with Needle Exchange Programs
February 2016
Map of states with Needle Exchange Programs
January 2016
50 state compilation and maps of overview of state pain management and prescribing policies. There are two main sections in the overview. The first section contains relevant information regarding state statutes, regulations and the guidelines related to the treatment of chronic pain and prescribing practices. Topics include: practitioner education requirements, pain treatment requirements or guidelines, referral of patients and limitations on the prescribing of Schedule II and Schedule III prescription drugs. The second section includes information related to the regulation of pain clinics and facilities with a focus on treatment of pain. Topics include: registration of pain clinics and treatment facilities, restrictions on who may own a pain clinic or treatment facility and requirement to have and responsibilities of a medical director. Subsections include a summary of the information within each subsection and may include state-specific provisions. At the end of each subsection is a national map or maps reflecting which states have the particular requirement or recommendation.
November 2015
2015 Summary and Analysis of Alabama’s prescribing, dispensing, pain management, pain clinic, medical marijuana and PDMP/PMP statutes and regulations
November 2015
2015 Summary and Analysis of Alaska's prescribing, dispensing, pain management, pain clinic, medical marijuana and PDMP/PMP statutes and regulations
Notice of Federal Funding Disclaimer
This website is funded in part through a cooperative agreement from the Bureau of Justice Assistance, Office of Justice Programs, U.S. Department of Justice and a grant from the Office of National Drug Control Policy. No federal instrumentality, including the Office of Drug Control Policy, the U.S. Department of Justice or its components, operate, control, are responsible for or necessarily endorse this website (including, without limitation, its content, technical infrastructure, policies and any services or tools provided).